HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
No edit summary |
No edit summary |
||
| Line 416: | Line 416: | ||
|Acute myeloid leukaemia with minimal differentiation | |Acute myeloid leukaemia with minimal differentiation | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| Line 432: | Line 432: | ||
|Acute myeloid leukaemia without maturation | |Acute myeloid leukaemia without maturation | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| Line 448: | Line 448: | ||
|Acute myeloid leukaemia with maturation | |Acute myeloid leukaemia with maturation | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| Line 464: | Line 464: | ||
|Acute basophilic leukaemia | |Acute basophilic leukaemia | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| Line 472: | Line 472: | ||
| | | | ||
| | | | ||
| | |Acute Basophilic Leukemia | ||
| | |Ashwini Yenamandra PhD FACMG | ||
| | |Complete | ||
| | | | ||
| | | | ||
| Line 480: | Line 480: | ||
|Acute myelomonocytic leukaemia | |Acute myelomonocytic leukaemia | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| Line 488: | Line 488: | ||
| | | | ||
| | | | ||
| | |Acute Myelomonocytic Leukemia | ||
| | |Fei Yang, MD, FACMG <br> Oregon Health & Science University | ||
| | |Complete | ||
| | | | ||
| | | | ||
| Line 496: | Line 496: | ||
|Acute monocytic leukaemia | |Acute monocytic leukaemia | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| Line 504: | Line 504: | ||
| | | | ||
| | | | ||
| | |Acute Monoblastic and Monocytic Leukemia | ||
| | |Fei Yang, MD, FACMG <br> Oregon Health & Science University | ||
| | |Complete | ||
| | | | ||
| | | | ||
| Line 512: | Line 512: | ||
|Acute erythroid leukaemia | |Acute erythroid leukaemia | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| Line 520: | Line 520: | ||
| | | | ||
| | | | ||
| | |Pure Erythroid Leukemia | ||
| | |Ashwini Yenamandra PhD FACMG | ||
| | |Complete | ||
| | | | ||
| | | | ||
| Line 528: | Line 528: | ||
|Acute megakaryoblastic leukaemia | |Acute megakaryoblastic leukaemia | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| Line 536: | Line 536: | ||
| | | | ||
| | | | ||
| | |Acute Megakaryoblastic Leukemia (AMKL) | ||
| | |Fei Yang, MD, FACMG <br> Oregon Health & Science University | ||
| | |Complete | ||
| | | | ||
| | | | ||
| Line 544: | Line 544: | ||
|Myeloid sarcoma | |Myeloid sarcoma | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| Line 552: | Line 552: | ||
| | | | ||
| | | | ||
| | |Myeloid Sarcoma | ||
| | |Yalda Naeini, MD, School of Medicine at University of California Los Angeles Fabiola Quintero-Rivera, MD, FACMG, School of Medicine at University of California Irvine | ||
| | |Complete | ||
| | | | ||
| | | | ||